ARKRAY USA Receives FDA Clearance On GLUCOCARD(TM) 01 Blood Glucose Monitoring System

Main Category: Diabetes
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 28 Jun 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.25 (4 votes)

Healthcare Prof:2 and a half stars

2.5 (2 votes)


ARKRAY USA, Inc. announced 510(k) clearance on GLUCOCARD(TM) 01 Blood Glucose Monitoring System.

GLUCOCARD(TM) 01

This new, affordable system requires no coding, displays results in 7 seconds, and requires a tiny 0.3 microliter sample size. GLUCOCARD(TM) 01 is AST approved and has a 360-count test memory with time and date stamp. It also features a large, easy-to-read display for better viewing of test results. The GLUCOCARD(TM) 01 is distinguished by its leading edge design and technology. Recent clinical data showed GLUCOCARD(TM) 01 to be highly accurate.

"ARKRAY is excited to announce a new addition to our growing line of GLUCOCARD(TM) blood glucose monitoring systems. The novel GLUCOCARD(TM) 01 system follows the GLUCOCARD(TM) brand image of sleek, compact, and discreet. The GLUCOCARD(TM) 01 appearance is similar to leading cell phone designs and unlike other glucose monitors on the market," said Jonathan Chapman, President of ARKRAY USA, Inc. "We look forward to building off the GLUCOCARD(TM) 01 technology and launching further systems later this year that will utilize the identical test strip."

About ARKRAY USA

ARKRAY has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self-testing systems. ARKRAY's primary focus throughout that time has been diabetes, developing the world's first hand held blood glucose meter (late 1960s) and the world's first HbA1c analyzer (1982). ARKRAY is one of the few diabetes testing companies in the US market today that undertakes in-house each step of the development process to bring products to market. ARKRAY is among the leading medical device companies noted for their patent-based intellectual property by Patent Board (Wall Street Journal 6/17/08). Worldwide, ARKRAY is the 5th largest blood glucose meter manufacturer.

ARKRAY USA
http://www.arkrayusa.com

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
ARKRAY USA. "ARKRAY USA Receives FDA Clearance On GLUCOCARD(TM) 01 Blood Glucose Monitoring System." Medical News Today. MediLexicon, Intl., 28 Jun. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/113166.php>

APA
ARKRAY USA. (2008, June 28). "ARKRAY USA Receives FDA Clearance On GLUCOCARD(TM) 01 Blood Glucose Monitoring System." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/113166.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »